News

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...
North Carolina man created a foundation to help other patients navigate expenses of an unexpectedly longer life ...
Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.
A small group of Australians with the rarest kinds of cystic fibrosis – fewer than 200 people – will, for the first time, ...
Take a straw and try to breathe through it. That's how Tayla Purves felt before she was placed on Trikafta. Ms Purves has cystic fibrosis, a genetic disease that primarily affects the lungs and ...
At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...
Affordable access to life-changing treatment for cystic fibrosis will be expanded to more Australians with a change to the ...
Keating and colleagues analyzed 398 patients (median age, 31 years; 59% male; 97% white) with cystic fibrosis aged at least 12 years who possessed the F508del-minimal function mutation in the ...
More Australians living with rarer types of cystic fibrosis will be able to access treatment for the first time when expanded ...
May 14—JAMESTOWN — For one Jamestown family, their first child was diagnosed with cystic fibrosis and each parent knew they were carriers of a mutated gene that causes the genetic disease. For ...